Table 4.
Adjusted OR (95% CI) | |
---|---|
Age | 0.95 (0.93 to 0.98) |
Gender (female versus male) | 0.50 (0.25 to 1.01) |
Race (AA versus non-AA) | 1.02 (0.48 to 2.20) |
Numeracy | 1.44 (1.01 to 2.07) |
Duration of follow-upb (per increase of 1 day) | 1.00 (1.00 to 1.01) |
n = 187.
Duration of follow-up: Elapsed days from date of study enrollment to last assessment of kidney transplant status.